Ovarian cancer after prophylactic salpingectomy in a patient with germline BRCA1 mutation Journal Article


Authors: Lugo Santiago, N.; Smith, E.; Sarasohn, D.; Cox, M.; Wan, C. S.; Tchabo, N. E.; Awowole, I.; Broach, V.; Chi, D. S.
Article Title: Ovarian cancer after prophylactic salpingectomy in a patient with germline BRCA1 mutation
Abstract: BACKGROUND: Women with germline BRCA1 or BRCA2 mutations have a lifetime risk of ovarian cancer of up to 46%. Opportunistic salpingectomy has been advocated as a risk-reducing strategy owing to increasing recognition of tubal origin, yet evidence of efficacy in this high-risk population is limited. CASE: This is the case of a woman with a BRCA1 mutation who underwent prophylactic mastectomy and bilateral salpingectomy with ovarian retention before the age of 40 years. She did not undergo oophorectomy and subsequently developed stage IV high-grade serous ovarian cancer 4 years after her initial surgery. CONCLUSION: More research is needed to determine the role of prophylactic salpingectomy with delayed oophorectomy, optimal timing of completion oophorectomy, and the risks and benefits compared with up-front risk-reducing salpingo-oophorectomy.
Journal Title: Obstetrics and Gynecology
Volume: 135
Issue: 6
ISSN: 0029-7844
Publisher: Lippincott Williams & Wilkins  
Date Published: 2020-06-01
Start Page: 1270
End Page: 1274
Language: English
DOI: 10.1097/aog.0000000000003864
PUBMED: 32459417
PROVIDER: scopus
PMCID: PMC7263355
DOI/URL:
Notes: Article -- Erratum issued for missing MSK author, see DOI: 10.1097/AOG.0000000000004064 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dennis S Chi
    707 Chi
  2. Vance Andrew Broach
    115 Broach
  3. Evan Scott Smith
    23 Smith